Page last updated: 2024-09-05

tak 779 and Injury, Ischemia-Reperfusion

tak 779 has been researched along with Injury, Ischemia-Reperfusion in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abe, T; Kaimori, J; Kakuta, Y; Matsunami, K; Miyagawa, S; Nonomura, N; Okumi, M; Otsuka, H; Takahara, S; Tsutahara, K; Yazawa, K1
Akahori, T; Kanehiro, H; Kashizuka, H; Nakajima, Y; Nomi, T; Sho, M1

Other Studies

2 other study(ies) available for tak 779 and Injury, Ischemia-Reperfusion

ArticleYear
The blocking of CXCR3 and CCR5 suppresses the infiltration of T lymphocytes in rat renal ischemia reperfusion.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2012, Volume: 27, Issue:10

    Topics: Amides; Animals; Base Sequence; CCR5 Receptor Antagonists; Ischemia; Kidney; Male; Natural Killer T-Cells; Quaternary Ammonium Compounds; Rats; Rats, Sprague-Dawley; Receptors, CCR5; Receptors, CXCR3; Reperfusion Injury; RNA, Messenger; T-Lymphocytes

2012
A novel CCR5/CXCR3 antagonist protects intestinal ischemia/reperfusion injury.
    Transplantation proceedings, 2006, Volume: 38, Issue:10

    Topics: Amides; Animals; CCR5 Receptor Antagonists; DNA Primers; Intestines; Male; Mesenteric Artery, Superior; Mice; Mice, Inbred C57BL; Polymerase Chain Reaction; Quaternary Ammonium Compounds; Receptors, CCR5; Receptors, Chemokine; Receptors, CXCR3; Reperfusion Injury; Survival Analysis

2006